| Heidmar Maritime Holdings Corp. Expands Ship Management Platform |
Globe Newswire |
07/07 |
07:40 |
| Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management |
Globe Newswire |
07/07 |
07:35 |
| Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026 |
Globe Newswire |
07/07 |
07:30 |
| ZenaTech’s ZenaDrone Advances Defense Drone Portfolio with Initial IQ Sphere Prototype for Autonomous GPS-Denied Inspections, Surveillance and Reconnaissance Missions |
Globe Newswire |
07/07 |
07:30 |
| South Plains Financial, Inc. Announces Second Quarter 2026 Earnings Call |
Globe Newswire |
07/07 |
07:30 |
| Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 |
Globe Newswire |
07/07 |
07:30 |
| BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ |
Globe Newswire |
07/07 |
07:30 |
| MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) |
Globe Newswire |
07/07 |
07:30 |
| Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy |
Globe Newswire |
07/07 |
07:05 |
| Why losing weight isn't just about counting calories — and what to do about it |
AP Online |
07/07 |
07:04 |
| Crypto News Today: Pepeto Staking Pays 169% APY While Solana Price Targets $600 |
Globe Newswire |
07/07 |
07:00 |
| Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement |
Globe Newswire |
07/07 |
07:00 |
| HMNC Brain Health Announces Publication of Ketabon (KET01) Clinical Trial Results in JAMA Network Open |
Globe Newswire |
07/07 |
07:00 |
| Endogenex Announces Full Enrollment of the ReCET Clinical Study |
Globe Newswire |
07/07 |
07:00 |
| AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026 |
Globe Newswire |
07/07 |
07:00 |
| Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535 |
Globe Newswire |
07/07 |
07:00 |
| U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease |
Globe Newswire |
07/07 |
07:00 |
| Solera Foundation’s WIND Movement Marks One Year of Global Impact, Spotlighting Darla Booher’s Leadership at NIADA Anniversary Celebration in Denver |
Globe Newswire |
07/07 |
07:00 |
| Aqua Metals Advances Headwaters ARC, Planned Midwest Battery Recycling and Critical Minerals Recovery Campus |
Globe Newswire |
07/07 |
07:00 |
| Miata Makes Significant New Discovery at Puma with 17.19 m at 3.14 g/t Au, and 21.64 m at 1.70 g/t Au |
Globe Newswire |
07/07 |
07:00 |
| Westhaven Announces the Start of Exploration at the Spences Bridge Gold Belt Properties, Southern British Columbia |
Globe Newswire |
07/07 |
07:00 |
| VR completes 2,900 ft hole and polyphase vein intersection at its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada; core scanning and continuous geochemistry are underway |
Globe Newswire |
07/07 |
07:00 |
| Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease |
Globe Newswire |
07/07 |
07:00 |
| Troilus Drills 164 m Grading 0.95 g/t AuEq While Testing Unsampled Historic Drillhole Intervals in the Z87 Reserve Pit |
Globe Newswire |
07/07 |
07:00 |
| Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD) |
Globe Newswire |
07/07 |
07:00 |
